These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 5073963)

  • 1. International Cancer Conference and Eighth International Pigment Cell Conference.
    Belisario JC
    Med J Aust; 1972 Jul; 2(3):166. PubMed ID: 5073963
    [No Abstract]   [Full Text] [Related]  

  • 2. Some aspects of the use of cytostatic drugs in dermatology.
    Falkson G
    S Afr Med J; 1966 Apr; 40(15):339-42. PubMed ID: 4160603
    [No Abstract]   [Full Text] [Related]  

  • 3. Podophyllotoxin for condylomata acuminata eradication. Clinical and experimental comparative studies on Podophyllum lignans, colchicine and 5-fluorouracil.
    von Krogh G
    Acta Derm Venereol Suppl (Stockh); 1981; 98():1-48. PubMed ID: 7046325
    [No Abstract]   [Full Text] [Related]  

  • 4. Local chemotherapy of cutaneous neoplasms.
    Klein E
    Proc Natl Cancer Conf; 1970; 6():501-15. PubMed ID: 5458119
    [No Abstract]   [Full Text] [Related]  

  • 5. [Dermatologic aspects of cutaneous pseudocancer].
    Nazzaro P
    Minerva Med; 1971 Apr; 62(30):1588-91. PubMed ID: 5556772
    [No Abstract]   [Full Text] [Related]  

  • 6. Retinoids in the management of non-melanoma skin cancer and melanoma.
    Craven NM; Griffiths CE
    Cancer Surv; 1996; 26():267-88. PubMed ID: 8783579
    [No Abstract]   [Full Text] [Related]  

  • 7. [Long-term results of the treatment of skin cancer with omain].
    Movsesian AKh
    Vopr Onkol; 1966; 12(9):8-12. PubMed ID: 6004077
    [No Abstract]   [Full Text] [Related]  

  • 8. The management of skin cancer with local chemotherapy: 5-fluorouracil.
    Va Med Mon (1918); 1968 Dec; 95(12):738-40. PubMed ID: 5725397
    [No Abstract]   [Full Text] [Related]  

  • 9. Optimizing regional therapy for melanoma.
    Beasley GM; Tyler DS
    Ann Surg Oncol; 2009 May; 16(5):1095-7. PubMed ID: 19189189
    [No Abstract]   [Full Text] [Related]  

  • 10. When will melanoma vaccines be proven effective?
    Sosman JA; Weeraratna AT; Sondak VK
    J Clin Oncol; 2004 Feb; 22(3):387-9. PubMed ID: 14691126
    [No Abstract]   [Full Text] [Related]  

  • 11. [Melanoma and non-melanoma skin cancers].
    Saito T
    Gan To Kagaku Ryoho; 2008 Apr; 35(4):583. PubMed ID: 18467999
    [No Abstract]   [Full Text] [Related]  

  • 12. Reaching first base in the treatment of metastatic melanoma.
    Eggermont AM
    J Clin Oncol; 2006 Oct; 24(29):4673-4. PubMed ID: 16966683
    [No Abstract]   [Full Text] [Related]  

  • 13. The prognostic importance of tumor mitotic rate confirmed in 1317 patients with primary cutaneous melanoma and long follow-up.
    Francken AB; Shaw HM; Thompson JF; Soong SJ; Accortt NA; Azzola MF; Scolyer RA; Milton GW; McCarthy WH; Colman MH; McGovern VJ
    Ann Surg Oncol; 2004 Apr; 11(4):426-33. PubMed ID: 15070604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune response modifiers and cutaneous neoplasia.
    Spencer JM
    Postgrad Med; 2002 Dec; 112(6 Suppl Using):17-21. PubMed ID: 19667609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer chemotherapy studies: cytoplasmic barrier in malignant epidermal cells against the effect of colchicine. An electron microscopic study in mice.
    Setälä K; Lindroos B; Nyyssönen O
    Acta Radiol Diagn (Stockh); 1966; ():Suppl 261:1-51. PubMed ID: 5964010
    [No Abstract]   [Full Text] [Related]  

  • 16. Isolated limb perfusion for melanoma.
    Kroon BB; Noorda EM; Vrouenraets BC; Nieweg OE
    J Surg Oncol; 2002 Apr; 79(4):252-5. PubMed ID: 11920783
    [No Abstract]   [Full Text] [Related]  

  • 17. Isolation-perfusion: a valuable alternative in managing locally recurrent and in-transit melanoma.
    Norvell ST; Bodurtha AJ
    Can J Surg; 1983 Jan; 26(1):8. PubMed ID: 6821770
    [No Abstract]   [Full Text] [Related]  

  • 18. [Our experience with the local chemotherapy of cutaneous precancerous conditions, epithelioma and of kerato-acanthoma].
    Basset A; Grosshans E; Maleville J
    Bull Soc Fr Dermatol Syphiligr; 1970 Jul; 77(1):116-7. PubMed ID: 5430023
    [No Abstract]   [Full Text] [Related]  

  • 19. 2nd International Conference on the Adjuvant Therapy of Malignant Melanoma. London, UK, 14-15 March, 1997. Report and abstracts.
    Retsas S; Falkson C
    Melanoma Res; 1997 Apr; 7(2):153-73. PubMed ID: 9167182
    [No Abstract]   [Full Text] [Related]  

  • 20. [Perfusion treatment of extremities in malignant melanoma. 9 year experience in 134 patients].
    Nachbur B; von Wattenwyl G; Goldhirsch A
    Helv Chir Acta; 1983 Jan; 49(5):629-32. PubMed ID: 6832996
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.